 Your new post is loading...
Your new post is loading...
|
Scooped by
Gilbert C FAURE
July 28, 2012 3:02 PM
|
PubMed comprises more than 21 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
|
|
Scooped by
Gilbert C FAURE
July 28, 2012 2:58 PM
|
Clinical Immunology Society Announces Updated WEBbook of Biologic ...DigitalJournal.com (press release)The Clinical Immunology Society (CIS) maintains the WEBbook of Biologic Therapies as a service to the Society members and the medical community...
|
|
Scooped by
Gilbert C FAURE
July 28, 2012 5:09 AM
|
OMT Announces New Antibody Discovery ProgramMarketWatch (press release)Open Monoclonal Technology, Inc. ("OMT") is a private biotechnology company that is the first to develop a fully human monoclonal antibody platform based on transgenic rats.
|
|
Scooped by
Gilbert C FAURE
July 28, 2012 2:46 AM
|
SAN DIEGO (CNS) - Researchers from San Diego State University's Heart Institute rejuvenated damaged cardiac tissue removed from older heart-failure patients, using modified stem cells.
|
|
Scooped by
Gilbert C FAURE
July 28, 2012 2:43 AM
|
“@Artritis_Celso:Ofatumumab, a fully human anti-CD20 monoclonal antibody, in biological-naive,RA pat.
|
|
Scooped by
Gilbert C FAURE
July 28, 2012 2:38 AM
|
Hematology Oncology | The FDA today approved everolimus for use in combination with exemestane to treat certain postmenopausal women with advanced hormone-receptor positive, HER-2–negative breast cancer.
|
|
Scooped by
Gilbert C FAURE
July 27, 2012 2:40 PM
|
Animal trials of Mesoblast's (ASX:MSB) mesenchymal stem cells in rheumatoid arthritis (RA) have encouraged the company press on with an FDA application for a phase II trial.
|
|
Scooped by
Gilbert C FAURE
July 27, 2012 2:38 PM
|
ADHERENT : Wolters Kluwer Health and The Transplantation Society Announce a Partnership to Advance Transplantation Jo http://t.co/c8mw0vpN...
|
|
Scooped by
Gilbert C FAURE
July 27, 2012 6:15 AM
|
Alethia Biotherapeutics Obtains a Notice of Allowance for a Patent for the Use ...MarketWatch (press release)MONTREAL, QUEBEC, Jul 23, 2012 (MARKETWIRE via COMTEX) -- Alethia Biotherapeutics Inc., a privately held pre-clinical stage biotechnology ...
|
|
Scooped by
Gilbert C FAURE
July 27, 2012 6:10 AM
|
Kidney transplant patients who received sirolimus (Rapamune) for immunosuppression were less likely to develop skin cancer than if they were given the older calcineurin inhibitors, a multicenter trial (Drug Cut Skin Cancers After Transplant
|
|
Scooped by
Gilbert C FAURE
July 27, 2012 4:56 AM
|
Mesoblast is seeking FDA approval to conduct a human clinical trial of its mesenchymal stem cells for treatment of rheumatoid arthritis, after seeing encouraging results in preclinical animal studies.
|
|
Scooped by
Gilbert C FAURE
July 26, 2012 3:23 PM
|
Biomarker, Oncology, cancer, Preclinical, Clinical, Companion Diagnostics, Epigenetics, translational medicine, Immunotherapies, Oncogenes, microarray, plasma proteins, tumor secretome...
|
|
Scooped by
Gilbert C FAURE
July 26, 2012 2:51 PM
|
Precision StemCell's Revolutionary InVivo Adult Stem Cell Reprogramming ...MarketWatch (press release)Located in Gulf Shores, Alabama, Precision StemCell conducts stem cell procedures using advanced imaging techniques, which include an Open 3T MRI,...
|
|
|
Scooped by
Gilbert C FAURE
July 28, 2012 3:01 PM
|
Uploaded and Shares in Youtube by: AssoEFP
Mechanism of action of dual-immunosuppression in solid organ transplantation.
EFP website: www.efp-online.org.
|
|
Scooped by
Gilbert C FAURE
July 28, 2012 2:52 PM
|
PubMed comprises more than 21 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
|
|
Scooped by
Gilbert C FAURE
July 28, 2012 4:21 AM
|
Posted: Jul 26th, 2012. Nanoscale scaffolds spur stem cells to cartilage repair. (Nanowerk News) A spun 3-D scaffold of nanofibers did a better job of producing larger quantities of and a more durable type of the cartilage protein than flat, 2-D ...
|
|
Scooped by
Gilbert C FAURE
July 28, 2012 2:43 AM
|
Stem-cell-based, tissue engineered tracheal replacement in a child: a 2-year follow-up study. By - Prof Martin J Elliott MD, Paolo De Coppi MD, Simone Speggiorin MD, Derek Roebuck MB, Colin R Butle...
|
|
Scooped by
Gilbert C FAURE
July 28, 2012 2:42 AM
|
Mark Donnison, managing director of Medical Australia, told Proactive Investors today the roll out of a new unique regenerative animal stem cell therapy offering in Europe presents the company with three potential revenue streams.
|
|
Scooped by
Gilbert C FAURE
July 27, 2012 2:41 PM
|
FDA 1. RSI 0.Regenerative Sciences (Regenexx) vs FDA (2012) via Cell Therapy Blog #celltherapy http://t.co/QERit2RB...
|
|
Scooped by
Gilbert C FAURE
July 27, 2012 2:38 PM
|
#Chlamydia trachomatis antigens that are capable of eliciting T cell and antibody responses (Michele Picard, et.
|
|
Scooped by
Gilbert C FAURE
July 27, 2012 12:40 PM
|
Systemic Combination Virotherapy For Melanoma With Tumor Antigen-Expressing Vesicular Stomatitis Virus And Adopt..
|
|
Scooped by
Gilbert C FAURE
July 27, 2012 6:14 AM
|
Intellect Neurosciences to Present at Antibody Summit in San FranciscoMarketWatch (press release)NEW YORK, Jul 23, 2012 (GlobeNewswire via COMTEX) -- Intellect Neurosciences, Inc. (otcpk:ILNS) announces Dr.
|
|
Scooped by
Gilbert C FAURE
July 27, 2012 4:57 AM
|
THE DESCRIPTION (Community-wide consensus process generates a framework for reporting of T-cell experiments in clinical immunology (http://t.co/95805vS9)!...)...
|
|
Scooped by
Gilbert C FAURE
July 26, 2012 4:01 PM
|
La presse médicale spécialisée. La Lettre Les Courriers Les Correspondances : la vie des spécialités.Des articles de synthèse intégralement accessibles en ligne, les archives depuis janvier 1998, l'actualité en cardiologie, en...
|
|
Scooped by
Gilbert C FAURE
July 26, 2012 2:52 PM
|
Pluristem, NIH to study stem cells to treat radiation syndromeReutersTEL AVIV, July 26 (Reuters) - Israel-based Pluristem Therapeutics Inc has received an invitation from the U.S.
|
Scoop.it!
